Navigating Regulatory Changes in Biotech Under New Leadership

This chapter examines Vinay Prasad's new position at the FDA and its potential effects on gene and cell therapy approvals. It highlights diverging expert opinions on his regulatory approach and how his personality may shape the future of rare disease therapies.